Levetiracetam (Keppra®) | UCB
UCB's Global Corporate Website

Levetiracetam (Keppra®)

Disease area studied Abbreviated title Phase Study ID Registry database Study results Plain language summary Publication (if available)
Epilepsy Phase 3 EP0100
Ongoing
NCT03340064
Epilepsy Phase 3 N01009
Completed
NCT00175890
2004-000199-14
LINK
PDF
PDF Pina-Garza et al. Epilepsia;2009;50(5);1141-1149.
Epilepsy Phase 3 N01020
Completed
NCT00160615 LINK
PDF
"Yagi, K., J Japan Epilepsy Society;2-10-2012;29;3;441-454 [In Japanese] "
Epilepsy Phase 4 N01031
Completed
NCT00630968 PDF Steinhoff et al. Epilepsy Res;2007;76(1);6-14.
Epilepsy Phase 4 N01033
Completed
NCT00643500 PDF Salas-Puig et al. Rev Neurol;2004;16-30;38;1117–1122. [in Spanish]
Epilepsy Phase 4 N01035
Completed
NCT00631150 PDF
Epilepsy Phase 4 N01036
Completed
NCT00160654 LINK
PDF
Kwan et al. Epilepsy Behav;2010;18(1-2);100-105.
Epilepsy Phase 4 N01037
Completed
NCT00630357 PDF
Epilepsy Phase 2 N01052
Completed
NCT00544050 PDF Glauser et al. Epilepsia;2007;48(6);1117-1122.
Epilepsy Phase 3 N01057
Completed
NCT00160550 PDF PDF Berkovic et al. Neurology;2007;69(18);1751-1760.
Epilepsy Phase 3 N01061
Completed
NCT00150735 PDF PDF Brodie et al. Neurology;2007;68(6);402-408.
Epilepsy Phase 4 N01085
Completed
NCT00245713 PDF
Anxiety Disorder Phase 2 N01086
Completed
NCT00612859 PDF "Stein, M. B. et al., Journal of Clinical Psychiatry;2010;71;5;627-631 "
Postherpetic Neuralgia Phase 2 N01087
Completed
NCT00160511 PDF
Epilepsy Phase 4 N01088
Completed
NCT00630630 PDF
Epilepsy Phase 3 N01093
Completed
NCT00150787 PDF Sethi et al. Neurology;2007;69(9);937-938.
Epilepsy Phase 3 N01099
Completed
NCT00160628 PDF Heo et al. Seizure;2007;16(5);402-409.
Epilepsy Phase 3 N01102
Completed
NCT00152373 PDF Wu et al. Epilepsia;2009;50(3);398-405.
Epilepsy Phase 2 N01103
Completed
NCT00105040
2014-004396-23
LINK
PDF
Levisohn et al. Epilepsia;2009;50(11);2377-2389.
Parkinson's Disease Phase 2 N01105
Completed
NCT00160576 PDF "Ferreira, J. Eur J Neurol;2004;11;Suppl 2;331 8th Congress of the European Federation of Neurological Societies (EFNS), September 4-7, 2004;Paris, France "
Epilepsy Phase 3 N01127
Completed
NCT00150813 LINK
PDF
Tardive Dyskinesia Phase 2 N01142
Completed
NCT00175955
2004-001302-27
PDF
Epilepsy Phase 3 N01148
Completed
NCT00152516
2004-000200-40
LINK
LINK
PDF Schiemann-Delgado et al.J Child Neurol;2012;27(1);80-89.
Epilepsy Phase 3 N01159
Completed
NCT01228747
2014-004401-32
LINK
LINK
Wu L., et al. Epilepsia Open 2018; 3(4):474–84
Epilepsy Phase 2 N01166
Completed
NCT00610454 PDF Baulac et al. Epilepsia;2007;48(3);589-592.
Epilepsy Phase 3 N01175
Completed
NCT00175903
2004-001339-41
LINK
PDF
"Trinka et al. J Neurol Neurosurg Psychiatry;2013;84(10);1138-1147 Pohlmann-Eden, B., et al. BMC Neurol;2016;16;1;149."
Epilepsy Phase 3 N01221
Completed
NCT00280696
2014-004333-57
LINK
PDF
PDF Inoue, Y. et al., Psychiatry Clin Neurosci;2015;69;10;640-648
Epilepsy Phase 3 N01222
Completed
NCT00367432
2014-004334-26
LINK
LINK
"Yagi, K., Japan J Clin Psychopharm;2016;19;1027-1040 [In Japanese] "
Epilepsy Phase 3 N01223
Completed
NCT01063764
2014-004335-39
LINK
LINK
Nakamura et al. Brain Nerve;2013;65(9);1083-1092. [in Japanese]
Epilepsy Phase 3 N01235
Completed
NCT00368069
2006-000987-10
LINK
LINK
Peltola et al. Epilepsia;2009;50(3);406-414.
Epilepsy Phase 3 N01237
Completed
NCT00291655
2006-000173-29
LINK
LINK
Epilepsy Phase 4 N01242
Completed
NCT00319605 Matías-Guíu et al. Methods Find Exp Clin Pharmacol;2010;32(7);507-516.
Epilepsy Phase 2 N01274
Completed
NCT00535392
2006-005722-23
LINK
LINK
PDF "Weinstock et al. J Child Neurol;2013;28(11);1423-1429. "
Epilepsy Phase 2 N01275
Completed
NCT00505934
2007-003517-13
LINK
LINK
PDF Weinstock et al. J Child Neurol;2013;28(11);1423-1429.
Epilepsy Phase 3 N01280
Completed
NCT00419094
2007-000897-21
LINK
LINK
Chung,S. et al. Epilepsy Res;2012;101(1-2);92-102.
Epilepsy Phase 3 N01281
Completed
NCT00419393
2007-000899-17
LINK
LINK
Chung, S., et al. Epilepsy Res;2016;120;7-12
Epilepsy Phase 2 N01340
Completed
NCT00961441
2014-004376-39
LINK
LINK
"Naritoku et al. Epilepsy Curr;2010;11;1 Suppl. 1. 64th Annual Meeting of the American Epilepsy Society (AES), December 3-7, 2010;San Antonio, USA."
Epilepsy Phase 4 N01353
Completed
NCT01229735
2014-004402-15
LINK
LINK
Lee S.K., et al. Epilepsy Behav 2019; 97:67–74
Epilepsy Phase 3 N01361
Completed
NCT01398956
2016-002879-96
LINK
LINK
Yagi K et al. Japan J Clin Psychopharm. 2018;21:1609-1622 [In Japanese]
Epilepsy Phase 3 N01363
Completed
NCT01292837
2014-004382-25
LINK
LINK
"Ohtsuka, Y. et al Japan J Clin Psychopharm;2016;19;3;347-359 [in Japanese]"
Epilepsy Phase 3 N01364
Completed
NCT01954121
2015-004586-84
LINK
LINK
PDF Liao W., et al. J Child Neurol 2020; 33(5) [In Chinese]
Epilepsy Phase 4 N01367
Completed
NCT01498822
2014-002713-32
LINK
LINK
"Kim, J. H. et al Epilepsia;2017;58;4;e70-e74 "
not applicable (pharmacokinetics study) Phase 4 N01373
Completed
NCT01491113 LINK
Yamamoto, J. et al., Clin Drug Investig;2014;34;11;819-828
Epilepsy Phase 3 N01375
Completed
NCT01506882
2014-004377-16
LINK
LINK
PDF Kaneko, S. et al. ,J Japan Epilepsy Society;2015;32;3;519-532 [ In Japanese]
Epilepsy Phase 2 N01378
Completed
NCT01407523 LINK
PDF Inoue, Y. et al., Jpn J Clin Psychopharmacol;2014;17;413-422 [In Japanese]
Epilepsy Phase 3 N157
Completed
NCT00150709 PDF " Glauser et al. Epilepsia;2005;46;Suppl 6;102. 26th International Epilepsy Congress (IEC), August 28-September 1, 2005;Paris, France. "
Epilepsy Phase 3 N159
Completed
NCT00615615 PDF PDF Glauser et al. Neurology;2006;66(11);1654-1660.
Epilepsy Phase 2 N164
Completed
NCT00545012 PDF
Epilepsy Phase 2 N165
Completed
NCT00600509 PDF Yagi, K. et al., J Japan Epilepsy Society;7-5-2010;28;1;3-16 [In Japanese]
Epilepsy Phase 3 N166
Completed
NCT00150774 PDF "Noachtar et al. Neurology;2-19-2008;70;8;607-616 Rosenfeld et al. Epilepsy Res;2009;85(1);72-80. "
Epilepsy Phase 3 N167
Completed
NCT00150748
2004-001997-13
LINK
PDF
Delanty et al. Epilepsia;2012;53(1);111-119.